Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2017

06.10.2016 | Breast Oncology

Ultrasound-Guided Core-Needle Versus Vacuum-Assisted Breast Biopsy: A Cost Analysis Based on the American Society of Breast Surgeons’ Mastery of Breast Surgery Registry

verfasst von: Ian Grady, MD, FACS, Tony Vasquez, MD, PhD, Sara Tawfik, MD, Sean Grady, BS

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the cost-efficacy of vacuum-assisted ultrasound-guided breast biopsy instruments compared to ultrasound-guided 14-gauge spring-loaded core-needle biopsy.

Methods

The American Society of Breast Surgeons’ Mastery of Breast Surgery Registry was reviewed. Biopsy findings, any rebiopsy, and the instrument used were abstracted for 31,451 ultrasound-guided biopsy procedures performed between 2001 and July 2014. Rates of cancer diagnosis and rebiopsy were calculated for each instrument. A linear mathematical model was developed to calculate total cost per cancer diagnosis, including procedural costs and the costs of any additional surgical rebiopsy procedures. Mean cost per cancer diagnosis with confidence limits was then determined for 14-gauge spring-loaded core-needle biopsy and 14 different vacuum-assisted instruments. For 14-gauge spring-loaded core-needle biopsy, mean cost per cancer diagnosis was $4346 (4327–$4366). For the vacuum-assisted instruments, mean cost per cancer diagnosis ranged from a low of $3742 ($3732–$3752) to a high of $4779 ($4750–$4809).

Results

Vacuum-assisted instruments overall were more cost-effective than core with a mean cost per cancer diagnosis of $4052 ($4038–$4067) (p < 0.05). Tethered vacuum-assisted instruments performed best with a mean cost per cancer diagnosis of $3978 ($3964–$3991) (p < 0.05). Nontethered devices had a mean cost per cancer diagnosis of $4369 ($4350–$4388), a result no better than core (p < 0.05).

Conclusions

Ultrasound-guided vacuum-assisted breast biopsy had a lower mean cost per cancer diagnosis than 14-gauge spring-loaded core-needle biopsy. This advantage was only seen in tethered vacuum-assisted instruments. Within device families, larger instruments tended to outperform smaller instruments.
Literatur
1.
Zurück zum Zitat Silverstein MJ, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.CrossRefPubMed Silverstein MJ, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.CrossRefPubMed
2.
Zurück zum Zitat Bruening W, et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152:238–46.CrossRefPubMed Bruening W, et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2010;152:238–46.CrossRefPubMed
3.
Zurück zum Zitat Jackman RJ, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485–8.CrossRefPubMed Jackman RJ, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485–8.CrossRefPubMed
4.
Zurück zum Zitat Philpotts LE, Hooley RJ, Lee CH. Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2003;180:347–51.CrossRefPubMed Philpotts LE, Hooley RJ, Lee CH. Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2003;180:347–51.CrossRefPubMed
5.
Zurück zum Zitat Yu YH, Liang C, Yuan XZ. Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review. Breast Cancer Res Treat. 2010;120:469–79.CrossRefPubMed Yu YH, Liang C, Yuan XZ. Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review. Breast Cancer Res Treat. 2010;120:469–79.CrossRefPubMed
6.
Zurück zum Zitat Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005;201:14–7.CrossRefPubMed Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005;201:14–7.CrossRefPubMed
7.
Zurück zum Zitat Kim MJ, et al. Breast lesions with imaging-histologic discordance during US-guided 14G automated core biopsy: can the directional vacuum-assisted removal replace the surgical excision? Initial findings. Eur Radiol. 2007;17:2376–83.CrossRefPubMed Kim MJ, et al. Breast lesions with imaging-histologic discordance during US-guided 14G automated core biopsy: can the directional vacuum-assisted removal replace the surgical excision? Initial findings. Eur Radiol. 2007;17:2376–83.CrossRefPubMed
8.
Zurück zum Zitat Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 2004;42:935–46, vii. Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 2004;42:935–46, vii.
9.
Zurück zum Zitat Jackman RJ, et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999;210:799–805.CrossRefPubMed Jackman RJ, et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999;210:799–805.CrossRefPubMed
10.
Zurück zum Zitat Jang M, et al. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2008;191:1347–51.CrossRefPubMed Jang M, et al. Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol. 2008;191:1347–51.CrossRefPubMed
12.
Zurück zum Zitat American Medical Association. Current procedural terminology. Standard ed. Chicago: American Medical Association; 2015. American Medical Association. Current procedural terminology. Standard ed. Chicago: American Medical Association; 2015.
15.
Zurück zum Zitat Mullahy J. Econometric modeling of health care costs and expenditures: a survey of analytical issues and related policy considerations. Med Care. 2009;47(7 Suppl 1):S104–8.CrossRefPubMed Mullahy J. Econometric modeling of health care costs and expenditures: a survey of analytical issues and related policy considerations. Med Care. 2009;47(7 Suppl 1):S104–8.CrossRefPubMed
16.
Zurück zum Zitat Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13:381–9.CrossRefPubMed Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13:381–9.CrossRefPubMed
17.
Zurück zum Zitat Blough DK. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1:185–202.CrossRef Blough DK. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1:185–202.CrossRef
18.
Zurück zum Zitat White GC, Bentts RE. Analysis of frequency count data using the negative binomial distribution. Ecology. 1996;77:2549–57.CrossRef White GC, Bentts RE. Analysis of frequency count data using the negative binomial distribution. Ecology. 1996;77:2549–57.CrossRef
19.
Zurück zum Zitat Feller W. Über den zentralen Genzwertsatz der Wahrscheinlichkeitsrechnung. Biometrika. 1935;40:521–59. Feller W. Über den zentralen Genzwertsatz der Wahrscheinlichkeitsrechnung. Biometrika. 1935;40:521–59.
Metadaten
Titel
Ultrasound-Guided Core-Needle Versus Vacuum-Assisted Breast Biopsy: A Cost Analysis Based on the American Society of Breast Surgeons’ Mastery of Breast Surgery Registry
verfasst von
Ian Grady, MD, FACS
Tony Vasquez, MD, PhD
Sara Tawfik, MD
Sean Grady, BS
Publikationsdatum
06.10.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5607-3

Weitere Artikel der Ausgabe 3/2017

Annals of Surgical Oncology 3/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.